News und Analysen
Nagarro increases its revenue guidance for FY 2022
Nagarro increases its revenue guidance for FY 2022
DGAP-Adhoc: Nagarro SE: Further increase in revenue guidance for FY 2022
DGAP-Adhoc: Nagarro SE: Further increase in revenue guidance for FY 2022
DGAP-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
DGAP-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
DGAP-News: CANCOM: CANCOM acquires S&L based in Mülheim-Kärlich
DGAP-News: CANCOM: CANCOM acquires S&L based in Mülheim-Kärlich
DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
DGAP-News: CANCOM: Rudolf Hotter leaves the Executive Board at his own request after 17 years. Rüdiger Rath becomes the new Chief Executive Officer of CANCOM SE
DGAP-News: CANCOM: Rudolf Hotter leaves the Executive Board at his own request after 17 years. Rüdiger Rath becomes the new Chief Executive Officer of CANCOM SE
DGAP-Adhoc: CANCOM SE: Rudolf Hotter resigns as Chief Executive Officer as of 31 October 2022; previous COO Rüdiger Rath appointed as successor
DGAP-Adhoc: CANCOM SE: Rudolf Hotter resigns as Chief Executive Officer as of 31 October 2022; previous COO Rüdiger Rath appointed as successor
DGAP-News: Evotec completes acquisition of Rigenerand
DGAP-News: Evotec completes acquisition of Rigenerand
DGAP-News: CANCOM: Annual General Meeting of CANCOM SE approves dividend increase to € 1.00 per share and all other agenda items
DGAP-News: CANCOM: Annual General Meeting of CANCOM SE approves dividend increase to € 1.00 per share and all other agenda items
DGAP-News: Siltronic AG successfully places ESG-linked promissory note loan of 300 million euros
DGAP-News: Siltronic AG successfully places ESG-linked promissory note loan of 300 million euros
DGAP-News: Evotec SE reports results of Annual General Meeting 2022
DGAP-News: Evotec SE reports results of Annual General Meeting 2022
DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
DGAP-News: Evotec enters a drug discovery collaboration with Janssen
DGAP-News: Evotec enters a drug discovery collaboration with Janssen
DGAP-News: Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47
DGAP-News: Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47
DGAP-News: MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
DGAP-News: MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
DGAP-News: Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand
DGAP-News: Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand
DGAP-News: freenet AG: freenet renews the very successful, exclusive partnership with Media-Saturn Deutschland GmbH until 2027
DGAP-News: freenet AG: freenet renews the very successful, exclusive partnership with Media-Saturn Deutschland GmbH until 2027
DGAP-News: Telefónica Deutschland Holding AG: Virtual Annual General Meeting resolved upon a dividend payment of EUR 0.18 per share for FY21
DGAP-News: Telefónica Deutschland Holding AG: Virtual Annual General Meeting resolved upon a dividend payment of EUR 0.18 per share for FY21
DGAP-News: Evotec and Almirall enter into a multi-target alliance in medical dermatology
DGAP-News: Evotec and Almirall enter into a multi-target alliance in medical dermatology
DGAP-News: MorphoSys AG Reports Outcome of Annual General Meeting 2022
DGAP-News: MorphoSys AG Reports Outcome of Annual General Meeting 2022
DGAP-News: Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
DGAP-News: Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes
DGAP-News: Nagarro Q1 2022 statement: Nagarro continues its rapid growth
DGAP-News: Nagarro Q1 2022 statement: Nagarro continues its rapid growth
DGAP-News: MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings
DGAP-News: MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings
DGAP-News: CANCOM: Very high IT as a Service growth rates lead to positive EBITDA development in the Group
DGAP-News: CANCOM: Very high IT as a Service growth rates lead to positive EBITDA development in the Group
